Fig 4.

(A) Landmark analysis at 2 years studying survival outcomes of patients undergoing early autologous stem-cell transplantation (ASCT) and achieving stringent complete response (sCR; n = 105) versus complete response (CR; n = 32). Median overall survival (OS) was not reached for patients with sCR, but patients achieving CR had median OS of 70 months (5.8 years; P = .007). (B) Among patients receiving early transplantations who achieved sCR (n = 109), OS of patients with sustained sCR (n = 75) at 6 months from ASCT was not reached (7-year OS, 86%) versus median OS of 66 months or 5.5 years for those who had nonsustained-sCR (n = 34) after ASCT (7-year OS, 37%; P < .001).